How do post-market surveillance and pharmacovigilance fit into the regulatory framework?
Post-market surveillance and pharmacovigilance are crucial for monitoring the safety of chemicals and pharmaceuticals after they enter the market. These processes involve collecting and analyzing data on adverse effects, ensuring that any emerging risks are identified and managed promptly. Regulatory agencies may require reporting of adverse events and can take actions such as updating safety labels, restricting use, or withdrawing products from the market if necessary.
